Descrizione libro Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this area. The first part of the book covers the definition, classification, pathophysiology, pathology, biomarkers and animal models of the disease, thus laying the conceptual basis for what follows. The middle section provides an overview of the established therapies, such as calcium channel blockers, prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors and inhaled nitric oxide. The last section explores novel pathways and emerging therapeutic approaches including soluble guanylate cyclase stimulators, Rho-kinase inhibitors, inhibitors of serotonin receptors and transporters, peptide growth factors, vasoactive peptides, modulators of redox equilibrium and cyclic nucleotide homeostasis, as well as immunosuppressive and anti-proliferative agents. Particular attention is given to the clinical applications of these experimental therapies, that are on the horizon. The book thus spans the continuum from basic science to clinical applications. 588 pp. Englisch. Codice articolo 9783662521571

Informazioni sul venditore | Contatta il venditore

Compra nuovo

EUR 374,49

Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 23,00

Da: Germania a: U.S.A.

Destinazione, tempi e costi

Immagini fornite dal venditore

Pharmacotherapy of Pulmonary Hypertension

Marc Humbert

Editore: Springer Berlin Heidelberg (2016)

ISBN 10: 3662521571 ISBN 13: 9783662521571

Nuovo Taschenbuch Quantit�: 1

Da:

AHA-BUCH GmbH
(Einbeck, Germania)

Valutazione libreria

Valutazione venditore:

Descrizione libro Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this area. The first part of the book covers the definition, classification, pathophysiology, pathology, biomarkers and animal models of the disease, thus laying the conceptual basis for what follows. The middle section provides an overview of the established therapies, such as calcium channel blockers, prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors and inhaled nitric oxide. The last section explores novel pathways and emerging therapeutic approaches including soluble guanylate cyclase stimulators, Rho-kinase inhibitors, inhibitors of serotonin receptors and transporters, peptide growth factors, vasoactive peptides, modulators of redox equilibrium and cyclic nucleotide homeostasis, as well as immunosuppressive and anti-proliferative agents. Particular attention is given to the clinical applications of these experimental therapies, that are on the horizon. The book thus spans the continuum from basic science to clinical applications. Codice articolo 9783662521571

Informazioni sul venditore | Contatta il venditore

Compra nuovo

EUR 378,98

Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 32,99

Da: Germania a: U.S.A.

Destinazione, tempi e costi

Foto dell'editore